WallStreetZenWallStreetZen

NASDAQ: KPTI
Karyopharm Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Karyopharm Therapeutics earnings were -$224.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest KPTI earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$67.0M, up 199.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KPTI reported annual earnings of -$196.0M, with 156.5% growth. The next KPTI earnings date is Nov 2, 2026.

KPTI earnings history

Current Revenue
$146.6M
Current Earnings
-$224.7M
Current Profit Margin
-153.3%

KPTI Return on Equity

Insufficient data to display

KPTI Return on Assets

Current Company
-200.9%
Current Industry
-10.2%
KPTI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KPTI announces earnings.

KPTI Return on Capital Employed

Current Company
765.61%
Current Industry
-6.7%
KPTI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KPTI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KPTI-$175.30M-$224.74MN/A-$14.16
FLNA-$41.30M-$42.28MN/A-$0.87
ATYR-$59.23M-$60.81MN/A-$0.62
CRVO-$30.35M-$30.35MN/A-$3.22
LITS-$60.82M-$60.82MN/A-$2.00
View Top Biotech Stocks

KPTI earnings dates

Next earnings date
Nov 2, 2026

Karyopharm Therapeutics Earnings Reports & History FAQ

What were Karyopharm Therapeutics's earnings last quarter?

On KPTI's earnings call on Aug 13, 2026, Karyopharm Therapeutics (NASDAQ: KPTI) reported Q2 2026 earnings per share (EPS) of -$2.32, up 46.3% year over year. Total KPTI earnings for the quarter were -$67.02 million. In the same quarter last year, Karyopharm Therapeutics's earnings per share (EPS) was -$4.32.

If you're new to stock investing, here's how to buy Karyopharm Therapeutics stock.

When does Karyopharm Therapeutics report earnings?

The next KPTI earnings call is Nov 2, 2026. Add KPTI to your watchlist to be reminded of Karyopharm Therapeutics's next earnings date.

Is Karyopharm Therapeutics profitable or losing money?

As of the last Karyopharm Therapeutics earnings report, Karyopharm Therapeutics is currently losing money. Karyopharm Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$224.74 million, a 81.88% increase year over year.

What was KPTI's earnings growth in the past year?

As of Karyopharm Therapeutics's earnings date in Aug 13, 2026, Karyopharm Therapeutics's earnings has grown year over year. KPTI earnings in the past year totalled -$224.74 million.

What are Karyopharm Therapeutics's earnings expectations?

The current EPS estimate for Karyopharm Therapeutics's earnings report in Nov 2, 2026 is -$1.15.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.